NeuroNexus is a global leader for innovative neural interface products and technologies to meet both current and upcoming needs in neuroscience research, neurosurgery, and neuromodulation.
NeuroNexus powers neuroscience research through innovative neural probes, systems, and data analytics software. NeuroNexus probes include a full line of high-quality, customizable microelectrode arrays for electrophysiology and optogenetics research. NeuroNexus systems provide integrated plug-and-play solutions to support diverse neurophysiology experiments and workflows. The NeuroNexus data analytics software platform provides powerful, scalable, cross-platform analytical and visualization tools for managing and analyzing neurophysiological data -- from individual experiments to complex multi-investigator 'big data'.
Thought Leaders, Inc. is a Delaware corporation formed on October 29, 2018. We are an emerging growth company. We develop reduced risk products (RRPs) for the tobacco industry that deliver the consumer sensory experience desired by smokers.
Our research and patent-pending product development efforts may also have valuable crossover applications for the delivery of pharmaceutical drugs. To date, we have invested more than $4 million to research, develop, and test our innovative heated tobacco products (HTPs). We have also built an exceptional team, which individually has decades of relevant tobacco product development, manufacturing, commercialization, and regulatory-leadership experience.
To achieve this goal, we plan to invest in superior technology, product testing and consumer research, product and brand development, and scalable marketing, sales, and distribution